The Newcastle upon Tyne Hospitals NHS Foundation Trust

Specialist MDT: The Newcastle upon Tyne Hospitals NHS Foundation Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services (updated 2022):

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under local anaesthetic
    • Transperineal biopsy under general anaesthetic
    • Transrectal ultrasound (TRUS) biopsy
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Isotope bone scan
    • One-stop diagnostic clinic
  • Treatment Facilities:
    • Radical prostatectomy
    • Robot assisted laparoscopic prostatectomy
    • External beam radiotherapy (EBRT)
    • Stereotactic body radiation therapy (SBRT)
    • Chemotherapy
  • Support Service Facilities:
    • Clinical Nurse Specialist (CNS) in all clinics
    • Prostate cancer-specific CNSs
    • Advanced PCa CNS
    • Urology CNS
    • Sexual function services
    • Specialist continence services
    • Genetic counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 261 869
Performance Status recorded 86% 69%
PSA completed 20% 38%
Gleason Score completed 79% 74%
TNM completed 76% 73%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 812 31258
Percentage of men diagnosed with metastatic disease 23% 19%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 130 3680
Percentage of men with low-risk localised disease receiving radical treatment 8% 9%
No. of men diagnosed with locally advanced disease 289 11503
Percentage of men diagnosed with locally advanced disease receiving radical treatment 70% 69%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (Apr 2021 - Mar 2022) 171
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 16%
No. of men who received radical prostatectomy (Sep 2019 - August 2020) 115
Adjusted percentage of men experiencing at least one GU complication (%) 6%
No. of men who received radical radiotherapy (Sep 2019 - August 2020) 379
Adjusted percentage of men experiencing at least one GI complication (%) 4%

Compare provider outcomes